NCT06430021View on ClinicalTrials.gov

Study of the Value of HPG80 (circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients with an MEN1 Mutation

RecruitingOBSERVATIONAL

Enrollment

297

Participants

Timeline

Start Date

June 13, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Neuroendocrine TumorsMEN1 Mutation

Interventions

BIOLOGICAL

blood sample

8 mL blood sample in EDTA tube

Trial Locations (1)

21000

RECRUITING

Chu Dijon Bourgogne, Dijon

All Listed Sponsors

lead

Centre Hospitalier Universitaire Dijon

OTHER